In hepatocellular carcinoma (HCC), NOD1 exerts an anti-tumor function by targeting the proto-oncogene SRC, leading to cell cycle arrest in the G1 phase and inhibition of the SRC–MAPK axis [101]. Here, SRC is linked to neoplasm.